In this episode, Arthur Kavanaugh, MD, explains what is new in psoriatic arthritis (PsA) in 2022, including new treatments, new treatment approaches, updates in the diagnosis PsA, and in safety...
Linda Grinnell-Merrick, MS, NP-BC, immediate past president of the Rheumatology Nurses Society, discusses the importance of a comprehensive evaluation of a patient with PsA, nonpharmacologic and...
He talks about the challenges of treating progressive psoriatic arthritis, why certain patients progress to more severe disease, and how to change medication when needed.
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how...
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how...
Dr Mease, from Swedish Medical Center, discusses his research on an interleukin-17a monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic arthritis.
Dr Mease, from Swedish Medical Center, discusses his research on an interleukin-17a monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic arthritis.
Philip J. Mease, MD, from Swedish Medical Center, discusses his research on an anti-interleukin-23p19 monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic...
Philip J. Mease, MD, from Swedish Medical Center, discusses his research on an anti-interleukin-23p19 monoclonal antibody that may be a potential therapeutic option for the treatment of psoriatic...
